BDTX Black Diamond Therapeutics Inc

USD 7.39 0.43 6.178161
Icon

Black Diamond Therapeutics Inc (BDTX) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Very Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 7.39

+0.43 (+6.18)%

USD 0.27B

0.90M

USD 13.00(+75.91%)

N/A

Icon

BDTX

Black Diamond Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 7.39
0.00 0
Take a Tour

Black Diamond Therapeutics Inc (BDTX) Stock Forecast

Show ratings and price targets of :
USD 13.00
(+75.91%)

Based on the Black Diamond Therapeutics Inc stock forecast from 3 analysts, the average analyst target price for Black Diamond Therapeutics Inc is USD 13.00 over the next 12 months. Black Diamond Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Black Diamond Therapeutics Inc is Very Bearish, which is based on 0 positive signals and 7 negative signals. At the last closing, Black Diamond Therapeutics Inc’s stock price was USD 7.39. Black Diamond Therapeutics Inc’s stock price has changed by +26.00% over the past week, +46.05% over the past month and +275.13% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...